WallStreetZenWallStreetZen

NASDAQ: IRLA
Irulya Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Irulya Therapeutics earnings were -$92.5M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest IRLA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$75.5M, down 310.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IRLA reported annual earnings of -$84.0M, with 47.8% growth. The next IRLA earnings date is Nov 11, 2026.

IRLA earnings history

Current Revenue
$0.0
Current Earnings
-$92.5M
Current Profit Margin
0%

IRLA Return on Equity

Current Company
N/A
Current Industry
-10.8%
Current Market
30.9%

IRLA Return on Assets

Current Company
-104.5%
Current Industry
-10.7%
IRLA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IRLA announces earnings.

IRLA Return on Capital Employed

Current Company
-81.94%
Current Industry
-7.4%
IRLA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IRLA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IRLA-$94.49M-$92.48MN/A-$142.31
RNAZ-$42.27M-$46.28MN/A-$52.37
NXTC-$40.68M-$42.75MN/A-$8.70
EDSA-$14.00M-$14.10MN/A-$1.69
IGC-$7.59M-$7.89MN/A-$0.08
View Top Biotech Stocks

IRLA earnings dates

Next earnings date
Nov 11, 2026

Irulya Therapeutics Earnings Reports & History FAQ

What were Irulya Therapeutics's earnings last quarter?

On IRLA's earnings call on Aug 17, 2026, Irulya Therapeutics (NASDAQ: IRLA) reported Q2 2026 earnings per share (EPS) of -$12.31, up 82.09% year over year. Total IRLA earnings for the quarter were -$75.49 million. In the same quarter last year, Irulya Therapeutics's earnings per share (EPS) was -$68.75.

If you're new to stock investing, here's how to buy Irulya Therapeutics stock.

When does Irulya Therapeutics report earnings?

The next IRLA earnings call is Nov 11, 2026. Add IRLA to your watchlist to be reminded of Irulya Therapeutics's next earnings date.

Is Irulya Therapeutics profitable or losing money?

As of the last Irulya Therapeutics earnings report, Irulya Therapeutics is currently losing money. Irulya Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$92.48 million, a 88.61% increase year over year.

What was IRLA's earnings growth in the past year?

As of Irulya Therapeutics's earnings date in Aug 17, 2026, Irulya Therapeutics's earnings has grown year over year. IRLA earnings in the past year totalled -$92.48 million.

What are Irulya Therapeutics's earnings expectations?

The current EPS estimate for Irulya Therapeutics's earnings report in Nov 11, 2026 is -$0.83.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.